A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial) | MicrobiomeTrials
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial)
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2024-07-31Est. Completion: 2026-10
Enrollment target: 56 participants
Locations
Rady Children's Hospital - San Diego, San Diego, California, United States
University of California San Francisco-Benioff Children's Hospital, San Francisco, California, United States
Prisma Health Pediatric Endocrinology, Columbia, South Carolina, United States
Instituto de Investigaciones Metabolicas (IDIM), Buenos Aires, Argentina
Centro Medico Dra Laura Maffei Investigacion Clinica Aplicada, Buenos Aires, Argentina
Centro de Investigaciones Medicas Mar del Plata, Mar del Plata, Argentina
Clinica Mayo de Urgencias Medicas Cruz Blanca S.R.L, San Miguel de Tucumán, Argentina
Hospital Da Criança de Brasília Jose Alencar, Brasília, Brazil
Hospital Universitario Walter Cantidio, Fortaleza, Brazil
Clínica de Endocrinologia e Metabologia Ltda, Lago Sul, Brazil
Nucleo de Pesquisa Clínica do Rio Grande do Sul-NPCRS, Porto Alegre, Brazil
CPQuali Pesquisa Clinica, São Paulo, Brazil
Irmandade Santa Casa de São Paulo, São Paulo, Brazil
Integral Pesquisa e Ensino, Votuporanga, Brazil
ENDOMET, Antofagasta, Chile
Other microbiome trials you might be interested in